Aditya Shah backs HDFC Bank, IT largecaps as value bets
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Aditya Shah named HDFC Bank as his top conviction pick, arguing that management-driven valuation compression has created an attractive long-term entry point for investors.
- Shah is also watching the life insurance and asset management spaces, naming HDFC Life, LIC, Nippon AMC, and HDFC AMC — while cautioning that AMC stocks are not cheap at current levels.
- Shah flagged Syngene and Piramal Pharma as potential longer-term plays in the CDMO sector, which he said remains under pressure globally.
- Shah said he expects muted results and uncertain management commentary from the upcoming IT earnings season as companies face slowing client spending and AI disruption.
- Largecap IT names now trade at P/E multiples of 10–18x with dividend yields of 3–4%, levels Shah called attractive for patient buyers even if terminal growth runs at just 1–2%.
- Shah told ET Now the market is 'a prisoner to what Donald Trump will do' but said short-term disruptions are not forever, urging investors to look at quality businesses with corrected stock prices.
Why it matters: Shah is explicitly positioning patient capital against the prevailing caution — recommending entries into HDFC Bank after management stumbles and into IT largecaps at 10–18x earnings with 3–4% yields, a stance that challenges the broader narrative that IT's AI disruption makes the sector uninvestable in the near term.
